Host: Gary Kohn, MD

Guest: Larry Dossey, MD

What do music, forgetting, and spirituality have to do with healing? Dr. Dossey suggests - a lot! Listen for some surprising connections and case examples.

Host: Gary Kohn, MD

Guest: Larry Dossey, MD

Dr. Dossey shares with us some simple and unusual concepts which can be healing for our patients and ourselves.

Host: Bill Rutenberg, MD

Guest: Ann Albright, PhD, RD

Just 7% of patients with diabetes are getting all the treatments they need and only 18% of these patients believe they are at increased risk for cardiovascular disease. In this segment, host Bill Rutenberg, MD and guest Ann Albright, Ph.D. discuss the strategies to enhance compliance, to improve the outcomes for patients with diabetes, and how to empower people to take charge and own their disease.

Host: Bill Rutenberg, MD

Guest: Ann Albright, PhD, RD

Diabetes translation brings research data into the clinical practice. In this segment join host Bill Rutenberg, MD and guest Ann Albright, Ph.D. in a discussion about early diabetes detection and prevention, and how the CDC is working to stem the tide of the diabetes epidemic.

Host: Susan Dolan, RN, JD

Guest: Brian Carter, MD

Join Dr. Brian Carter, Professor of Pediatrics in the Division of Neonatology at Vanderbilt Children's Hospital in Nashville, Tennessee, to discuss palliative care and hospice for the special care newborn.

Host: Susan Dolan, RN, JD

Guest: Brian Carter, MD

Dr. Brian Carter, professor of pediatrics in the division of neonatology at Vanderbilt's Children's Hospital in Nashville, Tennessee, discusses the special care newborn with host Susan Dolan.

Host: Bruce Bloom, DDS, JD

Guest: Denise L. Faustman, MD

Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.

Host: Bruce Bloom, DDS, JD

Guest: Denise L. Faustman, MD

Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cure.

Host: Mark Nolan Hill, MD

Guest: Mark Kirk, JD

Congressman Mark Kirk, vice chair of the congressional diabetes caucus speaks with host Dr. Mark Nolan Hill both about stem cell research and the challenging problem of solving the diabetes epidemic.

Host: Danny Petrasek, MD, PhD

Guest: Ronald Wilder, MD, PhD

How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.